JP Stock MarketDetailed Quotes

4597 Solasia Pharma KK

Watchlist

45
00.00%

20min DelayMarket Closed Nov 12 15:30 JST

9.82BMarket Cap-6797P/E (Static)

Solasia Pharma KK Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-80.58%60M

-95.00%11M

-43.50%617M

-97.53%15M

-75.25%73M

306.58%309M

94.69%220M

95.35%1.09B

119.93%607M

5,800.00%295M

Cost of revenue

-60.81%58M

-87.91%11M

-34.88%280M

-96.98%9M

-55.71%31M

377.42%148M

203.33%91M

132.43%430M

964.29%298M

70M

Gross profit

-98.76%2M

-49.09%337M

-98.06%6M

-81.70%41M

265.91%161M

56.10%128M

77.48%662M

25.00%310M

4,380.00%224M

Operating expense

-19.31%305M

-17.43%308M

-52.89%1.48B

-56.82%358M

-61.35%366M

-43.83%378M

-45.31%373M

12.17%3.13B

37.25%829M

34.14%947M

Selling and administrative expenses

-43.37%158M

-17.14%232M

-52.31%1.07B

-63.06%263M

-52.74%250M

-44.53%279M

-44.55%280M

15.50%2.25B

22.55%712M

5.38%529M

-General and administrative expense

-43.37%158M

-17.14%232M

-52.31%1.07B

-63.06%263M

-52.74%250M

-44.53%279M

-44.55%280M

15.50%2.25B

22.55%712M

5.38%529M

Research and development costs

48.48%147M

-18.28%76M

-54.36%403M

-18.80%95M

-72.25%116M

-41.76%99M

-47.46%93M

4.50%883M

408.70%117M

104.90%418M

Operating profit

-39.63%-303M

-25.71%-308M

53.91%-1.14B

32.18%-352M

55.05%-325M

65.50%-217M

59.17%-245M

-2.11%-2.47B

-45.79%-519M

-3.14%-723M

Net non-operating interest income (expenses)

-120.00%-3M

-10M

155.56%10M

100.00%2M

50.00%-7M

650.00%15M

21.74%-18M

150.00%1M

-14M

Non-operating interest income

--0

--10M

--2M

----

650.00%15M

--0

----

Non-operating interest expense

--3M

--10M

--0

-50.00%7M

--0

-21.74%18M

-150.00%-1M

--14M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

0.00%-1M

-66.67%-5M

50.00%-1M

0.00%-1M

-1M

-3M

-2M

-1M

Special income (charges)

Other non-operating income (expenses)

Income before tax

-52.22%-309M

-28.74%-318M

54.45%-1.14B

32.37%-351M

54.94%-333M

67.57%-203M

59.24%-247M

-2.05%-2.49B

-44.97%-519M

-5.57%-739M

Income tax

-33.33%-8M

-139.29%-22M

63.16%-7M

-103.28%-2M

-220.00%-6M

-175.00%-6M

60.00%56M

-311.11%-19M

306.67%61M

Net income

-52.79%-301M

-28.63%-310M

56.32%-1.11B

31.20%-344M

58.63%-331M

68.78%-197M

60.75%-241M

-2.87%-2.55B

-36.24%-500M

-11.89%-800M

Net income continuous operations

-52.79%-301M

-28.63%-310M

56.32%-1.11B

31.20%-344M

58.63%-331M

68.78%-197M

60.75%-241M

-2.87%-2.55B

-36.24%-500M

-11.89%-800M

Noncontrolling interests

Net income attributable to the company

-53.06%-300M

-28.63%-310M

56.36%-1.11B

31.06%-344M

58.68%-331M

68.99%-196M

60.81%-241M

-2.82%-2.55B

-35.97%-499M

-11.87%-801M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-53.06%-300M

-28.63%-310M

56.36%-1.11B

31.06%-344M

58.68%-331M

68.99%-196M

60.81%-241M

-2.82%-2.55B

-35.97%-499M

-11.87%-801M

Gross dividend payment

Basic earnings per share

-34.19%-1.57

-23.61%-1.78

60.52%-6.62

26.52%-2.05

60.20%-1.97

73.35%-1.17

68.76%-1.44

11.92%-16.77

-4.10%-2.79

9.34%-4.95

Diluted earnings per share

-34.19%-1.57

-23.61%-1.78

60.52%-6.62

26.52%-2.05

60.20%-1.97

73.35%-1.17

68.76%-1.44

11.92%-16.77

-4.10%-2.79

9.34%-4.95

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	-80.58%60M	-95.00%11M	-43.50%617M	-97.53%15M	-75.25%73M	306.58%309M	94.69%220M	95.35%1.09B	119.93%607M	5,800.00%295M
Cost of revenue	-60.81%58M	-87.91%11M	-34.88%280M	-96.98%9M	-55.71%31M	377.42%148M	203.33%91M	132.43%430M	964.29%298M	70M
Gross profit	-98.76%2M	0	-49.09%337M	-98.06%6M	-81.70%41M	265.91%161M	56.10%128M	77.48%662M	25.00%310M	4,380.00%224M
Operating expense	-19.31%305M	-17.43%308M	-52.89%1.48B	-56.82%358M	-61.35%366M	-43.83%378M	-45.31%373M	12.17%3.13B	37.25%829M	34.14%947M
Selling and administrative expenses	-43.37%158M	-17.14%232M	-52.31%1.07B	-63.06%263M	-52.74%250M	-44.53%279M	-44.55%280M	15.50%2.25B	22.55%712M	5.38%529M
-General and administrative expense	-43.37%158M	-17.14%232M	-52.31%1.07B	-63.06%263M	-52.74%250M	-44.53%279M	-44.55%280M	15.50%2.25B	22.55%712M	5.38%529M
Research and development costs	48.48%147M	-18.28%76M	-54.36%403M	-18.80%95M	-72.25%116M	-41.76%99M	-47.46%93M	4.50%883M	408.70%117M	104.90%418M
Operating profit	-39.63%-303M	-25.71%-308M	53.91%-1.14B	32.18%-352M	55.05%-325M	65.50%-217M	59.17%-245M	-2.11%-2.47B	-45.79%-519M	-3.14%-723M
Net non-operating interest income (expenses)	-120.00%-3M	-10M	155.56%10M	100.00%2M	50.00%-7M	650.00%15M	0	21.74%-18M	150.00%1M	-14M
Non-operating interest income	--0	--0	--10M	--2M	----	650.00%15M	--0	--0	--0	----
Non-operating interest expense	--3M	--10M	--0	--0	-50.00%7M	--0	--0	-21.74%18M	-150.00%-1M	--14M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests	0.00%-1M	0	-66.67%-5M	50.00%-1M	0.00%-1M	-1M	-1M	-3M	-2M	-1M
Special income (charges)
Other non-operating income (expenses)
Income before tax	-52.22%-309M	-28.74%-318M	54.45%-1.14B	32.37%-351M	54.94%-333M	67.57%-203M	59.24%-247M	-2.05%-2.49B	-44.97%-519M	-5.57%-739M
Income tax	-33.33%-8M	-33.33%-8M	-139.29%-22M	63.16%-7M	-103.28%-2M	-220.00%-6M	-175.00%-6M	60.00%56M	-311.11%-19M	306.67%61M
Net income	-52.79%-301M	-28.63%-310M	56.32%-1.11B	31.20%-344M	58.63%-331M	68.78%-197M	60.75%-241M	-2.87%-2.55B	-36.24%-500M	-11.89%-800M
Net income continuous operations	-52.79%-301M	-28.63%-310M	56.32%-1.11B	31.20%-344M	58.63%-331M	68.78%-197M	60.75%-241M	-2.87%-2.55B	-36.24%-500M	-11.89%-800M
Noncontrolling interests
Net income attributable to the company	-53.06%-300M	-28.63%-310M	56.36%-1.11B	31.06%-344M	58.68%-331M	68.99%-196M	60.81%-241M	-2.82%-2.55B	-35.97%-499M	-11.87%-801M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-53.06%-300M	-28.63%-310M	56.36%-1.11B	31.06%-344M	58.68%-331M	68.99%-196M	60.81%-241M	-2.82%-2.55B	-35.97%-499M	-11.87%-801M
Gross dividend payment
Basic earnings per share	-34.19%-1.57	-23.61%-1.78	60.52%-6.62	26.52%-2.05	60.20%-1.97	73.35%-1.17	68.76%-1.44	11.92%-16.77	-4.10%-2.79	9.34%-4.95
Diluted earnings per share	-34.19%-1.57	-23.61%-1.78	60.52%-6.62	26.52%-2.05	60.20%-1.97	73.35%-1.17	68.76%-1.44	11.92%-16.77	-4.10%-2.79	9.34%-4.95
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data